COVID-19 associated pulmonary aspergillosis (CAPA): An Australian case report
Avinash Sharma, Ann Hofmeyr, Anup Bansal, Devesh Thakkar, Leon Lam, Zinta Harrington, Deepak Bhonagiri
Abstract
As the COVID-19 pandemic has developed, concern for invasive fungal infections in critically ill COVID-19 patients with acute respiratory distress syndrome (ARDS) has emerged. We describe a clinical case of coronavirus disease (COVID-19) associated pulmonary aspergillus (CAPA) infection and acute respiratory distress syndrome (ARDS) with a good clinical outcome, in a previously well, non-immunocompromised Australian woman.
Topics & Concepts
ARDSMedicineCoronavirus disease 2019 (COVID-19)Acute respiratory distressIntensive care medicinePandemicPulmonary aspergillosisAspergillosisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)2019-20 coronavirus outbreakInfectious disease (medical specialty)LungImmunologyDiseaseVirologyInternal medicineOutbreakAntifungal resistance and susceptibilityNosocomial Infections in ICUBacterial biofilms and quorum sensing